EIKO logo

Eiko Lifesciences Ltd

EIKO·BSE·
₹51.75▲ +2.75 (+5.61%)
Market Cap73.36 Cr
PE Ratio15.87
Volume16,968
Day High - Low53.00 - 48.76
52W High-Low59.00 - 43.00

Eiko Lifesciences Ltd (EIKO): company summary

The company's business is improving, with annual revenue rising 40.0% and net profit jumping 129.3% year-over-year.

Eiko Lifesciences Ltd (EIKO) is a micro-cap Chemicals company valued at ₹73 crore operating in Specialty Chemicals on the NSE and BSE.

Recent price move
Eiko Lifesciences Ltd last traded at ₹51.75, sharply up 5.61% on the day.
Financial performance
The company's business is improving, with annual revenue rising 40.0% and net profit jumping 129.3% year-over-year. The latest quarter saw revenue and net profit grow 56.4% and 34.8% respectively compared to the same quarter a year earlier, while the net profit margin expanded 3.9 percentage points to 10.1%.
Valuation multiples
The stock trades at 15.9 times earnings, 1.01 times book value.
Things to watch
The stock is 16.9% below its 52-week high, and the company's market cap remains small at ₹70 crore. While the company is almost debt-free, its return on equity of 6.5% is relatively low, suggesting limited profitability relative to equity.
Where it stands
Eiko Lifesciences Ltd has delivered strong growth in both revenue and net profit over the past few years, with the latest quarter showing continued expansion. The stock is currently trading below its 52-week high, but the company remains almost debt-free with healthy margins.

Summarised by DocStoX's model on 2026-10-18 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.

DocStoX Score
5.8/10
Fair
Fair Value
Sign in to see
ROE
6.54%
Weak
P/E
15.87x
Fair
Debt / Equity
0.07
Low
Industry
Chemicals
Specialty Chemicals
Overall View
Mixed

Price performance

Day₹48.76
₹53.00
52W₹43.00
₹59.00
DocStoX take

Supported by growth (10.0) and valuation (6.1), but held back by quality (2.3). Growth looks strong at 10.0, but that is offset by quality at 2.3. We are calling it Mixed rather than resolving the conflict for you.

DocStoX score

Low confidence
5.8
/10
Fair
Quality
Weak
ROE 6.5%
Valuation
Fair
P/E 15.9×
Growth
Strong
Revenue +86.1% 5Y CAGR
Risk
Moderate
D/E 0.07
Momentum
Firm
55% of 52-week range

At a glance

Market Cap
₹73 Cr
52W High / Low
₹59 / ₹43
Dividend Yield
0.00%
Promoter Holding
39.96%
EPS (TTM)
₹3.26
Book Value
₹47.94

Key highlights

  • Profit compounding 93% a year
  • Revenue compounding 86% a year
  • Low leverage — D/E 0.07
  • Loss-making in some of the last 5 years
  • Quality is weak (2.3/10)
3 Positives3 Watchouts

Growth

Financials

Shareholding

Technicals

Peers

News

Forecasts

About the company

More data

Filings, corporate actions and ownership detail — opened on demand.

More Chemicals stocks · Specialty Chemicals

Eiko Lifesciences Ltd peers in Chemicals

Other Chemicals stocks on the NSE & BSE. See the full Chemicals sector list.